ArticleProstate cancer and prostatic diseases2022

Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer.

Bastiaan M Privé et al.PubMed ↗Publisher ↗

No numbers read from the abstract.